Litigation over the hair loss drug Propecia has picked up momentum with over 400 lawsuits pending in state and federal courts.
Irreconcilable contradictions in expert testimony prevented a product liability plaintiff from establishing that Merck failed to provide adequate warnings with the osteoporosis drug Fosamax, the 2nd Circuit has ruled in affirming judgment.
Since last year when the first lawsuits against Merck were filed over its hair loss drugs Propecia and Proscar, the number of suits has multiplied to approximately 1,000 cases in multidistrict litigation in U.S. District Court for the Eastern District of New York.
Six years after the first Fosamax lawsuit was filed, litigation over the osteoporosis drug is about to start a new chapter.
The suits against Merck, the drug’s manufacturer, fall into two categories: plaintiffs alleging they suffer from osteonecrosis, or jaw damage, and those claiming they suffered a non-traumatic femur fracture as a result of taking the drug.
Merck & Co. has agreed to pay at least $39 million into a fund to settle a Missouri class action over the marketing of the anti-inflammatory drug Vioxx, according to a tentative settlement agreement.
Merck & Co has agreed to pay between $3 million and $10 million to settle a nearly decade old class-action lawsuit that alleged the company made false claims about the benefits of its Coppertone sunscreen products.
Women who use birth control patches like Ortho-Evra or contraceptive vaginal rings like NuvaRing have a heightened risk of blood clots, a new medical study has found.
Merck will pay $5.1 million in attorney fees and institute corporate reforms under the terms of a settlement of a shareholder class action concerning the alleged suppression of negative clinical test results for the blockbuster anti-cholesterol drug Vytorin.
A Texas woman claims in a $10 million lawsuit against Merck that she suffered deep-vein thrombosis as a result of using the NuvaRing birth control device.
After mixed results in bellwether cases, and a recent string of defense verdicts, a special settlement master has been appointed to the Fosamax multidistrict litigation.